CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Clinical trial NCT05672147 · RECRUITING
Trial details
- NCT number
- NCT05672147
- Sponsor
- City of Hope Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-07
- Primary completion
- 2028-09-03
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.